Flow cytometry analysis revealed that, after 6 months from the first dose of mRNA vaccine, the IFN-γ-specific response is mainly detectable within the CD4+ T cells more than within the CD8+ T cell compartment, both in HCWs and in RA patients (Figures 8A, B). The gene discussed is CD4; the disease is rheumatoid arthritis.